Department of Cardiology, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Department of Geriatric Intensive Medicine, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Immun Inflamm Dis. 2023 May;11(5):e860. doi: 10.1002/iid3.860.
Sepsis-induced myocardial dysfunction (SIMD) is the leading cause of death in patients with sepsis in the intensive care units. The main manifestations of SIMD are systolic and diastolic dysfunctions of the myocardium. Despite our initial understanding of the SIMD over the past three decades, the incidence and mortality of SIMD remain high. This may be attributed to the large degree of heterogeneity among the initiating factors, disease processes, and host states involved in SIMD. Previously, organ dysfunction caused by sepsis was thought to be an impairment brought about by an excessive inflammatory response. However, many recent studies have shown that SIMD is a consequence of a combination of factors shaped by the inflammatory responses between the pathogen and the host. In this article, we review the mechanisms of the inflammatory responses and potential novel therapeutic strategies in SIMD.
脓毒症相关性心肌功能障碍(SIMD)是重症监护病房脓毒症患者死亡的主要原因。SIMD 的主要表现为心肌的收缩和舒张功能障碍。尽管我们在过去三十年对 SIMD 的初步认识有所提高,但 SIMD 的发病率和死亡率仍然很高。这可能归因于 SIMD 涉及的启动因素、疾病过程和宿主状态存在很大的异质性。以前,脓毒症引起的器官功能障碍被认为是过度炎症反应引起的损害。然而,许多最近的研究表明,SIMD 是病原体和宿主之间炎症反应综合作用的结果。在本文中,我们综述了炎症反应的机制和 SIMD 中潜在的新型治疗策略。